Literature DB >> 8175247

Chloroquine induced mania.

S Akhtar1, S Mukherjee.   

Abstract

OBJECTIVE: To find out whether chloroquine by itself can induce a manic syndrome and to study the course of illness in such cases.
METHOD: All cases of manic episodes occurring in clear consciousness were scrutinized and those occurring after the use of chloroquine were included in the study. One case seen by one of the authors in the community was included. The cases were followed for variable periods.
RESULTS: Six cases of chloroquine induced mania were identified of which two subtypes could be delineated with heterogeneous course, variable severity and difference in susceptibility of recurrence with rechallenge.
CONCLUSION: It is concluded that chloroquine can cause secondary mania and it should be used cautiously in the predisposed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8175247     DOI: 10.2190/8DRE-DBNH-MXXG-7AJF

Source DB:  PubMed          Journal:  Int J Psychiatry Med        ISSN: 0091-2174            Impact factor:   1.210


  9 in total

1.  A case of chloroquine-induced recurrent mania.

Authors:  Manjeet S Bhatia; Anurag Jhanjee; Anant Oberoi
Journal:  Prim Care Companion CNS Disord       Date:  2012-05-17

Review 2.  Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review.

Authors:  Sergio Marin; Alba Martin Val; Maite Bosch Peligero; Cristina Rodríguez-Bernuz; Ariadna Pérez-Ricart; Laia Vilaró Jaques; Roger Paredes; Josep Roca; Carles Quiñones
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-21

Review 3.  Adverse effects of chemotherapeutic agents used in tropical medicine.

Authors:  G C Cook
Journal:  Drug Saf       Date:  1995-07       Impact factor: 5.606

Review 4.  Drug-induced mania.

Authors:  M Peet; S Peters
Journal:  Drug Saf       Date:  1995-02       Impact factor: 5.606

5.  Psychiatric side effects of medications prescribed in internal medicine.

Authors:  Rodrigo Casagrande Tango
Journal:  Dialogues Clin Neurosci       Date:  2003-06       Impact factor: 5.986

6.  Preventing malaria in international travellers: an evaluation of published English-language guidelines.

Authors:  Merav Kliner; Kristina Poole; David Sinclair; Paul Garner
Journal:  BMC Public Health       Date:  2014-11-03       Impact factor: 3.295

7.  Remitting neuropsychiatric symptoms in COVID-19 patients: Viral cause or drug effect?

Authors:  David A Forero-Peña; Matthew M Hernandez; Iriana Paola Mozo Herrera; Iván Bolívar Collado Espinal; Joselyn Páez Paz; Carlos Ferro; David M Flora-Noda; Andrea L Maricuto; Viledy L Velásquez; Natasha A Camejo-Avila; Emilia M Sordillo; Lourdes A Delgado-Noguera; Luis A Perez-Garcia; Carlos G Morantes Rodríguez; María Eugenia Landaeta; Alberto E Paniz-Mondolfi
Journal:  J Med Virol       Date:  2021-11-19       Impact factor: 20.693

8.  Summary of recommendations on malaria issues in special hosts.

Authors:  A Boggild; J Brophy; P Charlebois; M Crockett; J Geduld; W Ghesquiere; P McDonald; P Plourde; P Teitelbaum; M Tepper; S Schofield; A McCarthy
Journal:  Can Commun Dis Rep       Date:  2014-05-15

9.  Psychiatric side effects of chloroquine in COVID-19 patients: two case reports.

Authors:  Roukaya Benjelloun; Yassine Otheman; Chafik El Kettani
Journal:  Pan Afr Med J       Date:  2020-06-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.